[Detection of erythrocyte antibodies using solid phase assays].

Area of Science:

• Blood group serology
• Immunohaematology
• Diagnostic assay development

Background:

• Blood group serology relies on antibody detection for transfusion safety.
• Conventional methods for antibody screening can be labor-intensive.
• Solid-phase assays offer potential for automation in serology.

Purpose of the Study:

• To compare the sensitivity and specificity of a solid-phase assay (SP-assay) against conventional antibody screening techniques.
• To evaluate the SP-assay's performance in detecting clinically significant irregular antibodies.
• To assess the rate of non-specific reactions with the SP-assay.

Main Methods:

• Comparison of the SP-assay (Biotest AG) with standard indirect antibody testing (IAT) and enzyme-linked tests.
• Screening of patient sera for irregular antibodies using both conventional and SP-assay methods.
• Analysis of positive and negative reaction patterns, including cold-reactive antibodies and non-specific reactions.

Main Results:

• The SP-assay demonstrated comparable sensitivity to the conventional indirect antibody test (IAT).
• Only 4% of cold-reactive antibodies detected by enzyme tests were positive in the SP-assay.
• The SP-assay yielded unspecific positive reactions in 7% of tested sera.
• Two additional antibodies (anti-D, immune anti-A) were detected by the SP-assay that were missed by conventional methods.

Conclusions:

• The SP-assay is a sensitive method for antibody screening in blood group serology, comparable to IAT.
• The assay's ability to detect certain antibodies missed by conventional techniques is advantageous.
• Careful interpretation is needed due to a 7% rate of unspecific positive reactions.